Armata Pharmaceuticals, Inc. (ARMP) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ARMP is $15.00, representing a +16.5% upside from the current price of $12.88. Price targets range from a low of $15.00 to a high of $15.00.
